Key result
Occult thyrotoxicosis affects ~13% of isolated AF patients, with antithyroid treatment linked to reduced arrhythmia recurrence.
Why the study?
Occult thyrotoxicosis may be present in patients with isolated atrial fibrillation without clinical or standard biochemical evidence of thyroid dysfunction.
Does full exploration of thyroid function, including TRH administration, identify occult thyrotoxicosis in patients with isolated atrial fibrillation?
Observational (n=40)
Does full exploration of thyroid function, including TRH administration, identify occult thyrotoxicosis in patients with isolated atrial fibrillation?
Full exploration of thyroid function, including TRH testing, is useful for identifying occult thyrotoxicosis in patients with both chronic and paroxysmal isolated atrial fibrillation.
Answers are grounded in this paper and cite their sources.
May support thyroid evaluation in isolated AF; leaves open whether antithyroid therapy reduces recurrence in trials.
Thyroid function tests, including thyrotropin releasing hormone administration (TRH), were performed in 40 consecutive patients with isolated atrial fibrillation (IAF) (i.e., without any other evidence of cardiac disease). The arrhythmia was chronic in 5 and paroxysmal in 35 patients. Thyrotoxicosis could not be diagnosed either clinically or by abnormal serum levels of T4, T3, T3 BC, and thyroid stimulating hormone (TSH). Thyroid stimulating hormone response to TRH, which was normal in 35 patients, was absent in 5 (12.5%) who were considered to have occult thyrotoxicosis. One had chronic and the other 4 had paroxysmal IAF. The arrhythmia did not recur after antithyroid treatment in these four patients who were in sinus rhythm after a mean follow-up period of 21 months. Full exploration of the thyroid function therefore seems useful not only in patients with chronic IAF, but also in those affected by the paroxysmal form.
No takes yet. Share an insight, caveat, or question.
Ciaccheri et al. (1984) conducted an observational in Isolated atrial fibrillation (n=40). Occult thyrotoxicosis was evaluated on Occult thyrotoxicosis (absent TSH response to TRH). Occult thyrotoxicosis was identified in 12.5% of patients with isolated atrial fibrillation, and antithyroid treatment prevented arrhythmia recurrence over a mean 21-month follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: